Latest filing published 18 Aug 2026 for Dolby Laboratories, Inc., €163k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Shriram Revankar (senior executive) discloses dealings in Dolby Laboratories, Inc. to SEC (Form 4). Between 16 May 2022 and 14 August 2026, the trades on record add up to 17 filings.
On the market, this insider has only sold: 4 sales, €953k in total. The rest of the record consists of 12 share grants and 1 option exercise. In 2026 alone, the filings show no purchases and 2 sales.
The record was last updated on 18 August 2026 with an open-market sale (€163k) in Dolby Laboratories, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations